The Cardiopulmonary Effects of the  Gene-related Peptide Family.

Tel, Banu Cahide; Telli, Gökçen; Gumusel, Bulent

dc.contributor.author	Tel, Banu Cahide
dc.contributor.author	Telli, Gökçen
dc.contributor.author	Gumusel, Bulent
dc.date.accessioned	2021-01-14T08:40:57Z
dc.date.available	2021-01-14T08:40:57Z
dc.date.issued	2020-06-01
dc.identifier.other	32636714
dc.identifier.uri	http://hdl.handle.net/20.500.12591/452
dc.description.abstract	Cardiopulmonary diseases are very common among the population. They are high-cost diseases and there are still no definitive treatments. The roles of members of the calcitonin-gene related-peptide (CGRP) family in treating cardiopulmonary diseases have been studied for many years and promising results obtained. Especially in recent years, two important members of the family, adrenomedullin and adrenomedullin2/intermedin, have been considered new treatment targets in cardiopulmonary diseases. In this review, the roles of CGRP family members in cardiopulmonary diseases are investigated based on the studies performed to date.	en_US
dc.language.iso	eng	en_US
dc.publisher	Ezcacılık Fakültesi	en_US
dc.rights	info:eu-repo/semantics/openAccess	en_US
dc.rights	Attribution-NonCommercial-NoDerivs 3.0 United States	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.subject	CGRP family	en_US
dc.subject	adrenomedullin	en_US
dc.subject	adrenomedullin2/intermedin	en_US
dc.subject	cardiopulmonary diseases	en_US
dc.subject	pulmonary hypertension	en_US
dc.title	The Cardiopulmonary Effects of the Gene-related Peptide Family.	en_US
dc.type	info:eu-repo/semantics/article	en_US
dc.contributor.department	Farmakoloji	en_US